Hernandez Joseph

CIK 00015983847 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001598384

Recent Transactions

34 trades

Sale
Blue Water Acquisition Corp. III$BLUW
Class A ordinary shares
2025-11-25−430,000→ 430,000 total
Other
Blue Water Acquisition Corp. III$BLUW
Class B ordinary shares
2025-11-25−6,325,000→ 0 total
Other
Blue Water Acquisition Corp. III$BLUW
Warrants to purchase Class A ordinary shares
2025-11-25−215,000→ 0 total
Purchase
Blue Water Acquisition Corp. III$BLUW
Class A ordinary shares
2025-06-11+430,000→ 430,000 total
Purchase
Blue Water Acquisition Corp. III$BLUW
Warrants to purchase Class A ordinary shares
2025-06-11+215,000→ 215,000 total
Award
Onconetix, Inc.$ONCO
Common Stock
2023-05-09+150,000→ 2,800,351 total
Sale
Onconetix, Inc.$ONCO
Common Stock
2022-08-22$4.10/sh−30,269→ 2,650,351 total
Sale
Onconetix, Inc.$ONCO
Common Stock
2022-08-19$4.21/sh−76,841→ 2,680,620 total
Sale
Onconetix, Inc.$ONCO
Common Stock
2022-08-18$4.96/sh−442,539→ 2,757,461 total
Award
Clarus Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-06-07+4,805→ 4,805 total
Award
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-06-07+1,922→ 1,243,266 total
Award
Onconetix, Inc.$ONCO
Stock Option
2022-05-04+200,000→ 200,000 total
Other
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-25+1,237,500→ 1,241,344 total
Other
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-25−65,000→ 1,237,500 total
Award
Clarus Therapeutics Holdings, Inc.
Warrants
2022-04-25$1.00/sh+3,445,000→ 3,445,000 total
Award
Clarus Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-12-12+9,610→ 9,610 total
Award
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-12-12+3,844→ 3,844 total
Other
CLARUS THERAPEUTICS INC
Common Stock
2021-09-09−135,000→ 1,302,500 total
Award
CLARUS THERAPEUTICS INC
Warrant
2021-09-09$1.00/sh+3,445,000→ 3,445,000 total
Exercise/Conversion
CLARUS THERAPEUTICS INC
Common Stock
2021-09-09+1,437,500→ 1,437,500 total
Exercise/Conversion
CLARUS THERAPEUTICS INC
Class B Common Stock
2021-09-09−1,437,500→ 0 total
Other
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-09-09−135,000→ 1,302,500 total
Award
Clarus Therapeutics Holdings, Inc.
Warrant
2021-09-09$1.00/sh+3,445,000→ 3,445,000 total
Exercise/Conversion
Clarus Therapeutics Holdings, Inc.
Class B Common Stock
2021-09-09−1,437,500→ 0 total
Exercise/Conversion
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-09-09+1,437,500→ 1,437,500 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-14$0.98/sh−870,854→ 0 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-13$0.80/sh−257,510→ 870,854 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-12$0.73/sh−629,707→ 1,128,364 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-11$0.77/sh−441,929→ 1,758,071 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-07$0.84/sh−323,997→ 2,200,000 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-06$0.60/sh−1,000,000→ 2,523,997 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-05$0.58/sh−500,000→ 3,523,997 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2021-01-04$0.52/sh−176,003→ 4,023,997 total
Sale
ORAGENICS INC$OGEN
Common Stock, $.001 par value
2020-12-02$0.41/sh−5,000,000→ 4,200,000 total

Companies

Recent Filings

Address

C/O BLUE WATER ACQUISITION CORP. III 15 E PUTNAM AVENUE, SUITE 363

GREENWICH, CT, 06830

View on SEC.gov